Willingness of WHO staff to work in health emergencies in the African Region: opportunity for phased deployment of staff and ensure continuity of health services

A human resource base that ensures appropriate deployment of staff to emergencies, addressing different shock events in emergencies, without disrupting continuity of service is germane to a successful response. Consequently, the WHO Health Emergencies programme in the African Region, in collaboration with Africa Centre for Disease Control (ACDC) launched the African Volunteer Health Corps (AVoHC) and Strengthening and Utilization of Response Group for Emergencies (SURGE), an initiative aimed at ensuring a pool of timely responders. We explored the willingness of WHO staff to work in emergencies. A call for expression of interest to be part of the Elite Emergency Experts (Triple E) was published on 5th July 2022 via email and was open for 5 weeks. The responses were analyzed using simple descriptive statistics and presented with graphic illustrations. A total of 1253 WHO staff, from all the six WHO regions, cutting across all cadre, applied to the call. The applicants had various trainings and experiences in emergency and have responded to mostly disease outbreaks. Two-third of the applicants were males. This paper did not explore reasons for the willingness to work in emergencies. However, contrary to fears expressed in literature that health workers would not want to work in emergencies with potential for infections, the applicants have worked mostly in infectious emergencies. Literature identified some themes on factors that could impact on willingness of health workers to work in emergencies. These include concerns for the safety of the responders and impact of partners, child and elderly care, as well as other family obligations, which emergency planners must consider in planning emergency response.

High Coverage of Vitamin A Supplementation and Measles Vaccination during an Integrated Maternal and Child Health Week in Sierra Leone.

Objectives: Mass distribution of vitamin A supplementation (VAS) and measles vaccination has contributed to the reduction in child mortality in Sierra Leone from 267/1000 in 2005 to 118/1000 in 2010. In May 2012, the twice-yearly Maternal and Child Health Week (MCHW) integrated VAS and supplementary measles vaccination to reach all children 6-59 months in Sierra Leone. Following the MCHW, a Post Event Coverage Survey (PECS) was conducted to validate coverage and assess Adverse Events Following Immunization (AEFI). Methods: Using WHO EPI sampling methodology, 30 clusters were randomly selected with fourteen caregivers of children 6-59 months interviewed per cluster for precision of ±5%. In addition, one health worker was interviewed per cluster with all responses collected via mobile phones using EpiSurveyor. Results: Overall coverage confirmed by campaign card for VAS and measles vaccination was 91.9% and 91.6%, respectively, with no significant differences by age group, sex, religion or occupation. Major reasons given for not receiving VAS and measles vaccination were not knowing about the MCHW or being out of the area. No serious AEFI’s were reported during the MCHW or PECs. Significantly more mild AEFIs (fever, pain at injection site) were reported via PECS (29.1%) than during the MCHW (0.01%) (p<0.0001). Conclusions: The MCHW reached >90% of children in Sierra Leone with equitable coverage. Increased reporting of mild AEFI’s during the PECs may be attributed to delayed onset after measles vaccination and/or direct enquiry from enumerators. While all reported AEFIs were mild, strengthened reporting of AEFIs during/after vaccination campaigns is recommended.